What do you do when metformin alone fails?
This content has been produced by Australian Doctor Group with an independent educational grant from MSD Australia.
At least 20% of patients with type 2 diabetes may be under-treated due to “clinical inertia”, research suggests.1,2
Australian guidelines provide a step-wise approach to management with clear first-line recommendations, but when it comes to second-line options, GPs may often lack confidence when choosing the right treatment and delay stepping up from metformin monotherapy to combination therapy.2–4
In addition, the failure to step up medication when needed may also be due to the array of treatment options that have become increasingly complex – especially when it comes to selecting second-line therapies available on the PBS.5
What are the clinical considerations when selecting a second-line option for your patients?
Check your skills with this quick quiz.
This content has been reviewed by GP consultant Dr Elizabeth Harris.